China Traditional Chinese Medicine Holdings Co. Limited
CHIZF
$0.275
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 564.70M | 567.43M | 578.98M | 584.00M | 610.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 564.70M | 567.43M | 578.98M | 584.00M | 610.70M |
| Cost of Revenue | 300.91M | 302.37M | 298.57M | 301.16M | 297.94M |
| Gross Profit | 263.79M | 265.06M | 280.41M | 282.84M | 312.77M |
| SG&A Expenses | 219.72M | 220.78M | 236.25M | 238.30M | 260.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -5.21M | -5.23M | 45.50K | 45.90K | -12.27M |
| Total Operating Expenses | 538.22M | 540.83M | 553.36M | 558.16M | 571.69M |
| Operating Income | 26.47M | 26.60M | 25.62M | 25.84M | 39.02M |
| Income Before Tax | -9.48M | -9.52M | 20.67M | 20.85M | 35.85M |
| Income Tax Expenses | 3.97M | 3.98M | 5.89M | 5.94M | -18.10M |
| Earnings from Continuing Operations | -13.44M | -13.51M | 14.79M | 14.91M | 53.95M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.53M | 2.55M | -218.50K | -220.40K | -5.03M |
| Net Income | -10.91M | -10.96M | 14.57M | 14.69M | 48.92M |
| EBIT | 26.47M | 26.60M | 25.62M | 25.84M | 39.02M |
| EBITDA | 63.15M | 63.46M | 62.68M | 63.22M | 75.61M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 5.04B | 5.04B | 5.04B | 5.04B | 5.04B |
| Average Diluted Shares Outstanding | 5.04B | 5.04B | 5.04B | 5.04B | 5.04B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | 0.00% |